Hisamitsu Pharmaceutical Co
4530.T
Filed as Hisamitsu Pharmaceutical Co.,Inc. (2022-07–2025-10)
Major holders (5%+) · 3
| Holder | Stake |
|---|---|
| TAIYO KOSAN CO., INC. | 32.13% |
| Nakatomi Kazuhide | 31.27% |
| CREDIT INDUSTRIEL ET COMMERCIAL | 9.43% |
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 12
| Invesco Asset Management (Japan) Limited | 3.77% |
| - | 1.08% |
| - | 0.68% |
| - | 0.40% |
| Invesco Hong Kong Limited | 0.12% |
| STM CO., INC. | 0.00% |
| SSTM CO., INC. | 0.00% |
| TKY CO., INC. | 0.00% |
| TM CO., LTD. | 0.00% |
| NAKATOMI KOSAN CO., INC. | 0.00% |
| NAKATOMI ASSET MANAGEMENT CO., INC. | 0.00% |
| - | 0.00% |
Ownership history · 51
| Holder | Ratio | Change |
|---|---|---|
| -2024-07-29 | 4.05% | no change |
| -2024-06-03 | 0.06% | -0.06pp |
| -2024-06-03 | 0.33% | no change |
| -2024-06-03 | 1.23% | -1.39pp |
| -2024-06-03 | 4.05% | -1.76pp |
| Invesco Hong Kong Limited2024-05-08 · amended | 0.12% | new |
| Invesco Asset Management (Japan) Limited2024-05-08 · amended | 3.77% | new |
| -2024-01-29 | 0.12% | new |
| -2024-01-29 | 0.33% | new |
| -2024-01-29 | 2.62% | new |
| -2024-01-29 | 5.81% | new |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.